(1)
Kandelouei, T.; Vaezjalali, M. Investigation of Relative Risk Factors of Hepatitis B Virus Core Antibody Positivity Among Intravenous Drug Users in Tehran, 2013. Novel Biomed 2017, 5, 65-70.